Skip to main content

Gastroenterology News

News
Use of gastric acid inhibitors is significantly associated with the likelihood of anti-allergic medications, according to the results of a recent study. Previous observational and animal studies have shown a relationship between gastric acid suppression and allergy, but how gastric acid inhibitors…
Newsfeed
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Patients taking oral proton pump inhibitors (PPIs) may be at increased risk of hip fracture, a meta-analysis of observational data suggests. "Physicians should, therefore, exercise caution when considering a long-term PPI treatment to their…
Newsfeed
By Lorraine L. Janeczko NEW YORK (Reuters Health) - Short-term proton-pump inhibitor (PPI) therapy has no clinically meaningful effect on bone turnover, a new study suggests. PPIs have been linked with osteoporotic fractures, but whether they directly cause osteoporosis remains unclear,…
Newsfeed
By Will Boggs MD NEW YORK (Reuters Health) - Men and women with inflammatory bowel disease (IBD) have a significantly increased risk of sexual dysfunction, according to a new meta-analysis. "As people get older, the prevalence of sexual dysfunction increases due to disturbance of hormones," said…
Newsfeed
By Megan Brooks NEW YORK (Reuters Health) - The choice of anticoagulant and proton-pump inhibitor (PPI) cotherapy may affect the risk of upper gastrointestinal-tract bleeding in the elderly, according to a large retrospective study of Medicare beneficiaries. The analysis included more than 1.6…
News
By Gene Emery (Reuters Health) - Giving intensive care unit (ICU) patients a proton-pump inhibitor (PPI) to prevent gastrointestinal bleeding does not seem to affect mortality, according to a European trial of nearly 3,300 adults. The 90-day death rate was 31.1% with 40 mg of the PPI pantoprazole…
News
New prescriptions of proton pump inhibitors (PPIs) are typically appropriately prescribed for patients with gastroesophageal reflux disease (GERD), but physicians often fail to discuss lifestyle changes with their patients, according to new findings. Because long-term use of PPIs may lead to…
News
By Reuters Staff NEW YORK (Reuters Health) - Naloxone is the safest and most effective treatment for opioid-induced constipation (OIC), according to a new review and network meta-analysis published in Gut. Using a different gauge of efficacy, naldemedine and alvimopan ranked first and second,…
News
Patients with liver cirrhosis who developed spontaneous bacterial peritonitis had worse outcomes if they were taking high doses of proton pump inhibitors (PPI), according to a study in published online in the journal Liver International (doi: 10.1111/liv.13862). “Thus, indication for high dosage…
News
By Will Boggs MD NEW YORK (Reuters Health) - Patients with inflammatory bowel disease (IBD) who receive anti-tumor necrosis factor (TNF) therapy have a reduced incidence of Parkinson’s disease (PD), compared with nonusers, according to a retrospective study. "Anti-TNFalpha therapy has been…
Back to Top